Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 3c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q1 EPS of ($0.48), $0.03 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Alpha Compute reports $1.57M monthly cash flow and $1.5B pipeline
• Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral